Panacea Life Sciences Holdings, Inc. Advertising Expense
Panacea Life Sciences Holdings, Inc. (PLSH) reported Advertising Expense of $220 for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2023-11-14
- Panacea Life Sciences Holdings, Inc. advertising expense for the quarter ending 2023-09-30 was $220.00, a 99.87% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. advertising expense for the quarter ending 2023-06-30 was $14.56K, a 53.49% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. advertising expense for the quarter ending 2022-09-30 was $168.66K.
- Panacea Life Sciences Holdings, Inc. advertising expense for the quarter ending 2022-06-30 was $31.31K.
- Panacea Life Sciences Holdings, Inc. advertising expense for fiscal 2020 was $61.12K, a 87.70% decline from fiscal 2019.
- Panacea Life Sciences Holdings, Inc. advertising expense for fiscal 2019 was $496.91K.
| Period end | Advertising Expense 3 month | Advertising Expense 3 month as first filed | Advertising Expense 6 month | Advertising Expense 9 month | Advertising Expense 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $220.00 10-Q · filed 2023-11-14 | $14.78K derived: sum of 2 quarters · filed 2023-11-14 | |||
| 2023-06-30 | $14.56K 10-Q · filed 2023-08-15 | ||||
| 2022-09-30 | $168.66K 10-Q · filed 2023-11-14 | $199.97K derived: sum of 2 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $31.31K 10-Q · filed 2023-08-15 | ||||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | $0.00 derived: sum of 2 quarters · filed 2021-04-23 | $4.08K derived: sum of 3 quarters · filed 2021-04-23 | $61.12K 10-K/A · filed 2021-04-23 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-18 | $4.08K derived: sum of 2 quarters · filed 2020-11-18 | $61.12K 10-Q · filed 2020-11-18 | $75.33K derived: sum of 4 quarters · filed 2021-04-23 | |
| 2020-06-30 | $4.08K 10-Q · filed 2020-08-19 | $61.13K 10-Q · filed 2020-08-19 | $75.33K derived: sum of 3 quarters · filed 2021-04-23 | $319.89K derived: sum of 4 quarters · filed 2021-04-23 | |
| 2020-03-31 | $57.05K 10-Q · filed 2020-06-29 | $71.25K derived: sum of 2 quarters · filed 2021-04-23 | $315.80K derived: sum of 3 quarters · filed 2021-04-23 | $610.89K derived: sum of 4 quarters · filed 2021-04-23 | |
| 2019-12-31 | $14.20K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | $258.75K derived: sum of 2 quarters · filed 2021-04-23 | $553.84K derived: sum of 3 quarters · filed 2021-04-23 | $496.91K 10-K/A · filed 2021-04-23 | |
| 2019-09-30 | $244.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-18 | $539.64K derived: sum of 2 quarters · filed 2020-11-18 | $482.71K 10-Q · filed 2020-11-18 | ||
| 2019-06-30 | $295.08K 10-Q · filed 2020-11-18 | $187.62K 10-Q · filed 2020-08-19 | $238.15K 10-Q · filed 2020-08-19 | ||
| 2019-03-31 | $50.53K 10-Q · filed 2020-06-29 |